NCT03185702 is a clinical trial of Research genetic tests in Turner Syndrome, sponsored by The University of Texas Health Science Center, Houston.

Who is sponsoring NCT03185702?

NCT03185702 is sponsored by The University of Texas Health Science Center, Houston.

What drugs are being tested in NCT03185702?

Interventions in NCT03185702: Research genetic tests.

What condition does NCT03185702 study?

NCT03185702 studies Turner Syndrome.

Is NCT03185702 still recruiting?

NCT03185702 is currently recruiting now. Last updated 28 November 2023.

Last reviewed 2023-11-28 · How we verify

NCT03185702

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

UTHealth Turner Syndrome Research Registry

Recruiting now Last updated 28 November 2023

What this trial tests

trial testing Research genetic tests in Turner Syndrome in 200 participants. Currently enrolling.

Timeline

28 August 2015

Primary endpoint
1 January 2030

1 January 2035

Quick facts

Lead sponsor	The University of Texas Health Science Center, Houston
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	200
Start date	28 August 2015
Primary completion	1 January 2030
Estimated completion	1 January 2035
Sites	1 location across United States

Drugs / interventions tested

Research genetic tests

Conditions studied

Turner Syndrome — all drugs for Turner Syndrome →

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Eligibility, female only, with Turner Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will conduct genetic comparisons between Turner Syndrome (TS) patients with and without Bicuspid Aortic Valve (BAV) to identify causative agents of BAV in people with TS. The investigators will correlate the patterns and prevalence of structural heart defects in TS women with emerging molecular data to identify patients who are at high risk for cardiovascular complications

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering.
Tenreiro MF, Louro AF, Alves PM, Serra M. · · 2021 · cited 98× · PMID 34075050 · DOI 10.1038/s41536-021-00140-4
Health disparities in Turner Syndrome: UTHealth Turner Syndrome Research Registry.
Donate P, Rivera-Davila M, Prakash SK. · · 2023 · cited 5× · PMID 37538978 · DOI 10.20517/rdodj.2023.02

Verify or expand the search:

Other recruiting trials for Turner Syndrome

Currently open trials in the same condition.

NCT06834594 — Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome · Phase 4 · recruiting
NCT06507007 — Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome · recruiting
NCT06794190 — Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants · recruiting
NCT06780514 — Cardiopulmonary Exercise Testing in Girls (8-18y) with Turner Sydrome. · NA · recruiting
NCT05723835 — A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9 · Phase 3 · active not recruiting

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03185702 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
Last refreshed: 28 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03185702.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing